169 related articles for article (PubMed ID: 35665804)
21. Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric ulcerative colitis.
Schechter A; Griffiths C; Gana JC; Shaoul R; Shamir R; Shteyer E; Bdolah-Abram T; Ledder O; Turner D
Gut; 2015 Apr; 64(4):580-8. PubMed ID: 24848266
[TBL] [Abstract][Full Text] [Related]
22. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
23. Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis.
Zeisler B; Lerer T; Markowitz J; Mack D; Griffiths A; Bousvaros A; Keljo D; Rosh J; Evans J; Kappelman M; Otley A; Kay M; Grossman A; Saeed S; Carvalho R; Oliva-Hemker M; Faubion W; Sudel B; Pfefferkorn M; Ashai-Khan F; Leleiko N; Hyams J;
J Pediatr Gastroenterol Nutr; 2013 Jan; 56(1):12-8. PubMed ID: 22847466
[TBL] [Abstract][Full Text] [Related]
24. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course.
Schirmer M; Denson L; Vlamakis H; Franzosa EA; Thomas S; Gotman NM; Rufo P; Baker SS; Sauer C; Markowitz J; Pfefferkorn M; Oliva-Hemker M; Rosh J; Otley A; Boyle B; Mack D; Baldassano R; Keljo D; LeLeiko N; Heyman M; Griffiths A; Patel AS; Noe J; Kugathasan S; Walters T; Huttenhower C; Hyams J; Xavier RJ
Cell Host Microbe; 2018 Oct; 24(4):600-610.e4. PubMed ID: 30308161
[TBL] [Abstract][Full Text] [Related]
25. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
[TBL] [Abstract][Full Text] [Related]
26. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
27. Histological healing after infliximab induction therapy in children with ulcerative colitis.
Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
[TBL] [Abstract][Full Text] [Related]
28. Identification and exploration of pharmacological pyroptosis-related biomarkers of ulcerative colitis.
Chen K; Shang S; Yu S; Cui L; Li S; He N
Front Immunol; 2022; 13():998470. PubMed ID: 36311726
[TBL] [Abstract][Full Text] [Related]
29. A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis.
Khan N; Patel D; Shah Y; Lichtenstein G; Yang YX
Inflamm Bowel Dis; 2017 Jun; 23(6):991-997. PubMed ID: 28328623
[TBL] [Abstract][Full Text] [Related]
30. Intensified Infliximab Induction is Associated with Improved Response and Decreased Colectomy in Steroid-Refractory Paediatric Ulcerative Colitis.
Church PC; Ho S; Sharma A; Tomalty D; Frost K; Muise A; Walters TD; Griffiths AM
J Crohns Colitis; 2019 Aug; 13(8):982-989. PubMed ID: 30715240
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and course of ulcerative colitis diagnosed in asymptomatic subjects.
Park SK; Ye BD; Yang SK; Kim SO; Kim J; Kim JW; Park SH; Yang DH; Jung KW; Kim KJ; Byeon JS; Myung SJ; Kim JH
J Crohns Colitis; 2014 Oct; 8(10):1254-60. PubMed ID: 24662395
[TBL] [Abstract][Full Text] [Related]
32. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
[TBL] [Abstract][Full Text] [Related]
33. Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis.
Kamm MA; Lichtenstein GR; Sandborn WJ; Schreiber S; Lees K; Barrett K; Joseph R
Inflamm Bowel Dis; 2009 Jan; 15(1):1-8. PubMed ID: 18671232
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.
Wine E; Mack DR; Hyams J; Otley AR; Markowitz J; Crandall WV; Leleiko N; Muise AM; Griffiths AM; Turner D
J Crohns Colitis; 2013 Dec; 7(11):916-22. PubMed ID: 23339932
[TBL] [Abstract][Full Text] [Related]
35. Carboxypeptidase A6 was identified and validated as a novel potential biomarker for predicting the occurrence of active ulcerative colitis.
Wang H; Zhang M; Zhang M; Wang F; Liu J; Zhao Q
J Cell Mol Med; 2020 Aug; 24(15):8803-8813. PubMed ID: 32570281
[TBL] [Abstract][Full Text] [Related]
36. Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids.
Bello C; Belaiche J; Louis E; Reenaers C
J Crohns Colitis; 2011 Jun; 5(3):196-202. PubMed ID: 21575881
[TBL] [Abstract][Full Text] [Related]
37. [Clinical outcome after discontinuation of infliximab in patients with ulcerative colitis in deep remission].
Muñoz Villafranca C; Bravo Rodríguez MT; Ortiz de Zárate J; Arreba González P; García Kamiruaga I; Heras Martín JI; Cabezudo Gil P; Orive Cura V
Gastroenterol Hepatol; 2016; 39(7):442-8. PubMed ID: 26948837
[TBL] [Abstract][Full Text] [Related]
38. Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study.
Garcia-Romero R; Martinez de Zabarte Fernandez JM; Pujol-Muncunill G; Donat-Aliaga E; Segarra-Cantón O; Irastorza-Terradillos I; Medina-Benitez E; Ruiz-Hernández CJ; Carrillo-Palau M; Ros-Arnal I; Rodriguez-Martínez A; Escartin-Madurga L; Gutiérrez-Junquera C; Vicente-Santamaría S; Velasco Rodriguez-Belvis M; Fernández-Fernández S; Alberto-Alonso JR; Montraveta M; Torres-Peral R; Navalon-Rubio M; Navas-López VM; Martin de Carpi J
Eur J Pediatr; 2021 Sep; 180(9):3029-3038. PubMed ID: 33880650
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis.
Harris RA; Nagy-Szakal D; Mir SA; Frank E; Szigeti R; Kaplan JL; Bronsky J; Opekun A; Ferry GD; Winter H; Kellermayer R
Epigenetics; 2014 Aug; 9(8):1131-7. PubMed ID: 24937444
[TBL] [Abstract][Full Text] [Related]
40. Single-cell RNA-sequencing combined with bulk RNA-sequencing analysis of peripheral blood reveals the characteristics and key immune cell genes of ulcerative colitis.
Dai YC; Qiao D; Fang CY; Chen QQ; Que RY; Xiao TG; Zheng L; Wang LJ; Zhang YL
World J Clin Cases; 2022 Nov; 10(33):12116-12135. PubMed ID: 36483809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
